Your browser doesn't support javascript.
loading
A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy.
Maguire, Melissa; Ben-Menachem, Elinor; Patten, Anna; Malhotra, Manoj; Ngo, Leock Y.
Afiliação
  • Maguire M; Leeds General Infirmary, Great George Street, Leeds, West Yorkshire LS1 3EX, UK. Electronic address: melissamaguire@nhs.net.
  • Ben-Menachem E; Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, Plan 0, 41345 Gothenburg, Sweden. Electronic address: elinor.ben-menachem@neuro.gu.se.
  • Patten A; Eisai Europe Ltd., EMEA Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK. Electronic address: Anna_Patten@eisai.net.
  • Malhotra M; Eisai Global Neurology Business Unit, 100 Tice Boulevard, Woodcliff Lake, NJ 07677, USA. Electronic address: Manoj_Malhotra@eisai.com.
  • Ngo LY; Eisai Global Neurology Business Unit, 100 Tice Boulevard, Woodcliff Lake, NJ 07677, USA. Electronic address: Stella_Ngo@eisai.com.
Epilepsy Behav ; 126: 108483, 2022 01.
Article em En | MEDLINE | ID: mdl-34953337

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia / Anticonvulsivantes Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia / Anticonvulsivantes Idioma: En Ano de publicação: 2022 Tipo de documento: Article